A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Clinical trial NCT06617000 · RECRUITING
Trial details
- NCT number
- NCT06617000
- Sponsor
- SCG Cell Therapy Pte. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-25
- Primary completion
- 2025-12-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.